Industry: Pharmaceuticals (See others in industry)
Address:Date | FilingType | Incremental Cash | Link to Raw Filing | |||
---|---|---|---|---|---|---|
2025-05-06 | New | $12,288,567 | $12,288,567 | Equity Only | 06b | SEC link |
2024-05-15 | Amended | $10,143,750 | $4,323,850 | Equity Only | 06b | SEC link |
2023-12-05 | New | $5,819,900 | $5,819,900 | Equity Only | 06b | SEC link |
Name | Role |
---|---|
Michael Berendt | Director |
Eric Keller | Director, Executive |
Donald Olds | Director |